A phase II study evaluating abscopal effect of nivolumab in combination with local radiotherapy in patients with pretreated metastatic non-small cell lung cancer
- Conditions
- on-small cell Lung Cancer
- Registration Number
- JPRN-UMIN000023838
- Lead Sponsor
- Department of Respiratory, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 17
Not provided
(1) Active double cancer(except for some early or cured cancer as followe:carcino ma in situ, mucosal cancer, stage I prostate, breast, or laryngeal cancer) (2) History of pericardial effusion, pleural effusion, and ascites which drainage treatment is needed (3) patients with clinically disease progression, such as obvious PS deterioration by nivolumab administration (4) radiation field includes the lung (5) Positive serum HBs antigen (6) Radiographically confirmed interstitial pneumonitis or pulmonary fibrosis (7) Patients with a clinically severe complication (8) History of severe drug allergy (9) women who are or may be pregnant or in lactatoin (10) patients judged to be unsuitable for this study by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method